NCT04319276 2025-11-03Oral Gallium Maltolate for the Treatment of Relapsed and Refractory GlioblastomaMedical College of WisconsinPhase 1 Active not recruiting26 enrolled
NCT00050687 2011-01-28Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory MalignanciesTitan PharmaceuticalsPhase 1/2 Terminated